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Regulatory RNA research has marked a new paradigm
of RNA-directed gene expression regulation and the most
promising voice of the post-genomic era in developing new
drugs and therapeutics for various diseases. It helps to
determine what genes are accessible to each type of cell,
a crucial choice for multicellular animals that require, for
e x a m p l e ,al i v e rc e l lt or e a do ﬀ one set of genes and a brain
cell to be governed by a diﬀerent set. And it coordinates
suites of genes that may be under diﬀerent control systems
but need to act together in response to sudden stresses.
The generation of a huge amount of sequences from a
number of key organisms and complementary development
of computational bio-tools for regulatory RNA annotation
and analysis, have accelerated this ﬁeld of research. The small
RNAshavebeenaboontoscientistsbringingreversegenetics
to assess the function of a gene. The new regulatory role
of RNA began to emerge in the last 10 years as researchers
discoveredaclassofshortRNAmoleculesknownassilencing
RNAs and a second class called micro-RNAs. And these
probably constitute the tip of the iceberg. The opportunity
to harness the tantalizing ﬁeld of regulatory RNA mediated
RNA interference (RNAi) pathway in silencing disease-
causing genes hold great promise for the development of
therapeutics directed against targets that are not addressable
with current medicines. Bioinformatics as well plays a major
role and aids in analyzing, interpreting and screening of such
RNA sequences and their targets.
MicroRNAs are only the best studied members of the
expanding family of regulatory non-coding RNAs that
populates all domains of life. MicroRNAs tell us many
stories like stories of evolution, with their quickly evolving
and adaptable structures that exploded in animal and plant
genomes through duplication of existing microRNAs and
exaptation of elements that served other functions such as
snoRNAs. They tell us stories of development, with their
intricate role in the diﬀerentiation of so many tissues,
including animal brain, immune cells and muscle, as well as
plantorgans.Theyarealsocloselyinvolvedinhumandisease.
An astounding 1700 papers have been published about RNA
and cancer since the ﬁrst report of downregulated miRNAs
in cancer cells in 2002.
With the revelation that most intergenic and junk DNA
in eukaryotic genomes was actually transcribed, a whole
new understanding of the non-messenger transcriptome is
emerging, where transcripts produced during RNA poly-
merase initiation or as the result of cleavage by a variety of
Dicer-like enzyme are acting in regulating gene expression
at many diﬀerent levels. Regulatory RNAs are also gaining
importance in the prokaryotic world in the form of trans-
acting small RNAs and cis-acting riboswitches which, just
as their eukaryotic counterparts, are able to switch genes
on and oﬀ with exquisite accuracy in response to various
environmental challenges,triggering deepchangesin cellular
functions that are reminiscent of the developmental events
triggered by miRNAs in multi-cellular organisms. There is
a long way ahead in introducing this huge diversity of RNA
molecules into our global picture of cellregulatory networks.
As our understanding of the functions of small RNAs and2 Journal of Biomedicine and Biotechnology
their mode of regulation continues to increase, we will be
able to translate these regulatory RNAs from lab-to-clinic for
therapeutic applications.
This area of research has attracted some of the most
innovative research groups in the molecular biology and
bioinformatics ﬁeld and as Editors, we are truly privileged
that many of these investigators have contributed to this
issue. We express our sincere gratitude to the contributing
authors as well as to the vision of the Founder Editor,
Dr Abdelali Haoudi, for this opportunity provided by the
Journal of Biomedicine and Biotechnology.
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